ConforMIS Board of Directors Gains New Member

ConforMIS Inc., a developer of proprietary iFit image-to-implant technology that creates joint replacement implants customized to fit each patient’s unique anatomy, announced today that its Board of Directors elected Philip W. Johnston to the board beginning with the annual shareholders’ meeting in early May. Johnston will be up for election by all stockholders at that meeting.
 
“Phil’s broad experience, including his significant public and private experience in health care policy, will add a valuable perspective to our Board of Directors,” said Kenneth P. Fallon, III, board chairman.  “We appreciate his willingness to serve as a director and look forward to benefitting from his judgment and counsel.” 
 
Johnston has served in senior positions in the Massachusetts legislature, the Massachusetts State cabinet, and the U.S. government, including as the New England administrator of the U.S. Department of Health and Human Services under President Bill Clinton, and twice as chair of the Massachusetts Democratic Party.  Additionally, Johnston has served as a member of the Board of Trustees of the University of Massachusetts, the chairman and vice chairman of the University of Massachusetts Building Authority Board of Directors, and the vice chair of the University of Massachusetts Foundation.
 
Since 1998, he has served as a member of the Board of Directors of Blue Cross Blue Shield of Massachusetts, and in 2002, he was appointed as chair of the Board of the Blue Cross Blue Shield of Massachusetts Foundation. Johnston currently serves as the board chair of the Massachusetts Health Policy Forum. He also has held a number of other roles in the public and private sector.  Presently, Johnston is president and founder of Philip W. Johnston Associates LLC, a communications and public affairs consulting firm that he established in 1996.

“We welcome the addition of Phil to our board and look forward to working with him,” added Mark Augusti, ConforMIS’ president and CEO. “His experience and knowledge in the payor and provider environment will be a tremendous asset for ConforMIS.”
 
ConforMIS offers a broad line of customized knee implants and pre-sterilized, single-use instruments delivered in a single package to the hospital. In recent clinical studies, ConforMIS iTotal CR demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. ConforMIS owns or exclusively in-licenses approximately 450 issued patents and pending patent applications that cover customized implants and patient-specific instrumentation for all major joints. The company is based in Bedford, Mass.